TORONTO, April 27,
2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or
the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMZC), the global medical
cannabis leader expanding throughout Latin America and Europe, today announces that it will host a
conference call on Monday, May
2nd , 2022 at 10:00 a.m.
Eastern Time to discuss its financial results for year ended
and quarter ended December 31, 2021.
The Company will press release its financial results prior to the
conference call. These filings will be available for review on the
Company's SEDAR profile at www.sedar.com
Khiron invites individual and institutional investors, as well
as advisors and analysts, to attend the Company's YE and Fourth
Quarter 2021 Conference Call, followed by a Q&A session.
Conference Call Date: May
2nd, 2022
Time 10:00 a.m. Eastern time
Toll-free dial-in number: 1-888-664-6383
International dial-in number: 1-416-764-8650
Please call the conference telephone number 5-10 minutes prior
to the start time. An operator will register your name and
organization. If you have any difficulty connecting with the
conference call, please contact Khiron Investor Relations team at
(647) 556-5750
A telephonic replay of the conference call will also be
available after 8:00 p.m. Eastern
time on the same day through June
2nd , 2022.
Toll-free replay number: 1-888-390-0541
International replay number: 1-416-764-8677
Replay ID: 935848
About Khiron Life Sciences
Corp.
Khiron is a leading vertically integrated international medical
cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health
clinics and proprietary telemedicine platforms, Khiron combines a
patient-oriented approach, physician education programs, scientific
expertise, product innovation, and agricultural infrastructure to
drive prescriptions and brand loyalty with patients worldwide. The
Company has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in
Mexico. The Company is led by
Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and
diverse executive team and Board of Directors.
Visit Khiron online at investors.khiron.ca
Linkedin
https://www.linkedin.com/company/khiron-life-sciences-corp/
Forward-Looking
Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment on
analyses, expectations or statements made by third-parties in
respect of Khiron, its securities, or financial or operating
results (as applicable). Although Khiron believes that the
expectations reflected in forward-looking statements in this press
release are reasonable, such forward-looking statement has been
based on expectations, factors and assumptions concerning future
events which may prove to be inaccurate and are subject to numerous
risks and uncertainties, certain of which are beyond Khiron's
control, including the risk factors discussed in Khiron's Annual
Information Form which is available on Khiron's SEDAR profile at
www.sedar.com. The forward-looking information contained in this
press release is expressly qualified by this cautionary statement
and is made as of the date hereof. Khiron disclaims any intention
and has no obligation or responsibility, except as required by law,
to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this press release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/khiron-to-host-ye-and-fourth-quarter-2021-conference-call-on-may-2-2022-301534717.html
SOURCE Khiron Life Sciences Corp.